This multicentre, randomised, double-blind, placebo-controlled trial enrolled 4228 patients with reduced left ventricular function (ejection fraction <35%) but without symptomatic heart failure.
The addition of enalapril to the conventional heart failure treatment resulted in a significant 37% decrease in the incidence of heart failure.
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page